多参数扩散权重的MRI用于初级阿尔多斯顿症患者的脏微结构评估,在不同的直接宁度下进行
Deying Wen1, Ailin Liang1, Qinglin Du1
1West China Hospital of Sichuan University, Chengdu, China.
Abdominal radiology (New York)
|August 18, 2025
概括
多参数扩散加权成像 (DWI) 检测了原发性阿尔多斯特隆症 (PA) 的微结构变化. 异常的直接宁度 (DRC) 与改变的功能生物标志物相关,有助于非侵入性PA监测.
科学领域:
- 放射学 放射学是一门学科.
- 腎臟病學 (nephrology) 是一種醫學專業.
- 医疗成像医学成像
背景情况:
- 原发性阿尔多斯特隆症 (PA) 可能导致脏微观结构损伤.
- 评估PA的脏变化,特别是直接宁度 (DRC),对于患者管理至关重要.
- 需要使用非侵入性成像技术来量化这些变化.
研究的目的:
- 采用多参数扩散权重成像 (DWI) 来检测和量化PA患者的微结构变化.
- 研究DWI衍生的生物标志物和变化的直接宁度 (DRC) 之间的关系.
- 探索DWI生物标志物和功能指数之间的相关性.
主要方法:
- 50名PA患者和32名健康对照 (HCs) 接受了3.0TMRI,使用单指数式,内不连贯运动和拉伸指数式DWI模型.
- 扩散参数 (ADC, f, Ds, Df, DDC, α) 被两个独立观察员分析.
- 统计分析包括t测试,曼·惠特尼U,ANOVA,ROC曲线分析和相关性测试 (皮尔森/斯皮尔曼).
主要成果:
- 与HC相比,患有DRC异常的PA患者表现出较低的皮层/髓层ADC,f,DDC和较高的皮层α (AUC=0.884).
- 在异常DRC组与正常DRC组 (AUC=0.790) 中,骨髓f减少.
- 功能生物标志物与扩散指标相关:骨髓Ds与肌素相反,骨髓f与尿酸相反,皮质DDC与肌素/囊素C相反.
结论:
- 多参数DWI有效地检测和量化PA中的脏微结构异常.
- 异常的DRC与更显著的脏微观结构变化有关.
- 酒后驾驶生物标志物显示出非侵入性监测PA相关损伤的潜力.
相关概念视频
Antihypertensive Drugs: Direct Renin Inhibitors
819
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
819
Imaging Studies IV: Magnetic Resonance Imaging
52
Introduction:Magnetic Resonance Imaging, or MRI, can include a specialized imaging technique of the urinary system known as Magnetic Resonance Urography (MRU). This radiation-free technique uses strong magnetic fields and radio waves to produce detailed images with the help of a computer. MRU is particularly effective for visualizing fluid-filled structures like the kidneys, ureters, and bladder.Applications of MRI in the Genitourinary SystemKidneys and Ureters: MRI detects tumors, cysts,...
52
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
505
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
505
Imaging Studies VII: Vascular Imaging
54
DefinitionRenal angiography, also known as renal arteriography, is an imaging technique used to obtain a comprehensive view of blood flow and the vascular structure of blood vessels in the kidneys and surrounding areas.PurposeRenal angiography detects blood vessel abnormalities in the kidneys, such as aneurysms, stenosis, thrombosis, vascular tumors, and renal artery stenosis. It evaluates kidney function and guides interventional treatments like angioplasty or stent placement.Pre-Procedure...
54
Factors Affecting Renal Clearance: Renal Impairment
157
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
157


